Clinical Trial Update: Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial investigating neoadjuvant anti-PD-1 immunotherapy combined with chemotherapy for resectable locally advanced oral squamous cell carcinoma is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Snippet

Sponsor: Hospital of Stomatology, Wuhan University | Conditions: Oral Squamous Cell Carcinoma | Phase 3 | Status: RECRUITING